GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805502/0/en/GeoVax-Appoints-Dr-Marc-Pipas-as-Executive-Medical-Director-Oncology.html

Strengthening GeoVax’s Team Advancing Gedeptin® Clinical Program

ATLANTA, GA, Jan. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the appointment of J. Marc Pipas, M.D., to serve as the Company’s Executive Medical Director, Oncology. 

Read more at globenewswire.com

Related news for (GOVX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.